Keheng shares: signed a cooperation framework agreement with Gree supply chain, and Keheng shares announced that the company and its wholly-owned subsidiaries Yingde Keheng, Zhuhai Keheng, Zhuhai Haoneng and Haoneng Technology signed a cooperation framework agreement with Gree supply chain. Gree supply chain granted Jiangmen Keheng, Yingde Keheng, Zhuhai Keheng, Zhuhai Haoneng and Haoneng Technology a total of 650 million yuan in raw material procurement business.Huabei Pharmaceutical Co., Ltd.: Four kinds of drugs under the company are planned to be selected for national centralized drug procurement. Huabei Pharmaceutical announced that the company and its subsidiary Xiantai Company participated in the tenth batch of national centralized drug procurement, and all four varieties are planned to be selected, including penicillin sodium for injection, piperacillin sodium for injection, ampicillin sodium for injection and sulbactam sodium for injection. The price of the drug to be selected this time has decreased compared with the original sales price. In 2023, the sales income of penicillin sodium for injection was 129 million yuan, accounting for 1.28% of the annual operating income. If the bid is confirmed and the purchase and sale contract is signed, the company will fully guarantee the supply according to the demand of the selected area, and promote the increment of related products in the selected area and the development of the off-standard market.Kexing launched the world's first phase III clinical study of bivalent inactivated enterovirus vaccine. On December 13th, the first volunteer was enrolled in the phase III clinical study of bivalent inactivated enterovirus vaccine developed by Beijing Kexing Biological Products Co., Ltd., a subsidiary of Kexing Holding Biotechnology Co., Ltd. (hereinafter referred to as "Kexing"). The vaccine is used to prevent hand, foot and mouth disease caused by enterovirus 71 (EV71) and coxsackie virus 16 (CA16). A multicenter, randomized, double-blind, controlled study design was adopted in this phase III clinical study to evaluate the protective efficacy, safety and immunogenicity of the vaccine in children aged 6-71 months.
Joint Statement by the Foreign Ministers of People's Republic of China (PRC) and the Arab Republic of Egypt (full text) and Joint Statement by the Foreign Ministers of People's Republic of China (PRC) and the Arab Republic of Egypt 1. On December 13, 2024, Commissioner the Political Bureau of the Communist Party of China (CPC) Central Committee and Foreign Minister Wang Yi held a strategic dialogue with Egyptian Minister of Foreign Affairs and Immigration Abdul Atti. 2. The two sides exchanged in-depth and comprehensive views on China-Egypt relations and international and regional issues of common concern, and jointly reviewed the development achievements made by the two countries since the establishment of diplomatic relations, especially since the establishment of a comprehensive strategic partnership 10 years ago. 3. The two sides stressed the need to implement the important consensus reached by the two heads of state at their two meetings in 2024, take the "China-Egypt Year of Partnership" as a new starting point, and push bilateral relations to a higher goal of building a community of destiny between China and Egypt facing the new era. The two sides appreciated the many diplomatic, economic, trade, investment, cultural and tourism activities held by the two countries this year to promote and develop bilateral relations in various fields. (Xinhua News Agency) BYD Lian Yubo: It is estimated that BYD will sell 4.25 million vehicles in the whole year. On December 13th, BYD's chief scientist Lian Yubo said: "Up to now, BYD has sold more than 10 million new energy vehicles. By the end of this month, we can probably achieve the annual sales of 4.25 million vehicles. " He also mentioned: "There are still some challenges in industrial development. For example, the overall anti-risk ability of our industrial chain needs to be improved, and there are still breakthroughs in chips, operating technologies, industrial software and nuclear materials. We still need to strengthen research and achieve complete autonomy and controllability."
Gong Zheng, Mayor of Shanghai, investigates Shanghai Electric Group: If the growth point of emerging industries is identified, he will increase investment and cultivate growth. Gong Zheng, Deputy Secretary of Shanghai Municipal Committee and Mayor, pointed out in the investigation of Shanghai Electric Group today (13th) that Shanghai Electric bears the great mission of innovation and development of high-end equipment industry, and should further focus on its main business, make efforts to "strengthen the foundation and revitalize the new", make the energy level bigger and stretch the long board longer. Consolidating the foundation is to focus on consolidating the basic disk of high-end equipment manufacturing, enhance the initiative of transformation in advantageous areas, increase the intensity of transformation, and expand domestic and foreign markets. Promoting innovation is to focus on cultivating the growth point of emerging industries, increase investment when it is clear, cultivate and grow as soon as conditions are ripe, take the lead in seizing the commanding heights, and strive to break new paths and advance in promoting new industrialization and cultivating new quality productivity. (The Paper)South Korean courts issued arrest warrants for police chief Zhao Zhihao and Seoul police chief Jin Feng Yong. On December 13th, local time, Seoul Central District Court issued arrest warrants for police chief Zhao Zhihao and Seoul police chief Jin Feng Yong. (CCTV News)State-owned Assets Supervision and Administration Commission (SASAC): Actively expand effective investment, improve investment efficiency, and focus on the layout of a number of major projects with strong traction and long-term benefits. The Party Committee of the State Council SASAC held a special meeting. The meeting stressed that it is necessary to promote central enterprises to improve their ability to cope with cyclical fluctuations, continue to exert efforts in performance appraisal, quality improvement and efficiency improvement, and economic operation, and strive to simultaneously improve efficiency and efficiency indicators, and strive to achieve development with stronger scientific and technological attributes and greater driving role; Actively expand effective investment, improve investment efficiency, focus on "two" and "two new" layout of a number of major projects with strong traction and long-term benefits; We will do a better job in helping small and medium-sized enterprises, promote central enterprises to deepen strategic cooperation in the industrial chain, take the lead in paying off debts owed by private enterprises, and go all out to stabilize employment, supply and flow, so as to better help the national economy continue to pick up. It is necessary to promote the central enterprises to improve the supply capacity of common technologies, further highlight the key points and strengthen the key core technologies, especially in areas with large investment and long cycle; Further highlight the original innovation, explore and create a "policy enclave", strengthen the applied basic research, and deeply root the "root technology"; Further highlight the transformation of achievements, promote the construction of a number of major pilot projects by central enterprises, and constantly open up the "last mile" of the transformation of scientific and technological achievements into real productive forces, so as to better help high-level science and technology stand on its own feet. (SASAC)
Strategy guide
12-14
Strategy guide
12-14